Upregulation of ANLN expression plays an important role in non-small cell lung cancers (NSCLC) by activating RHOA and participating in the phosphoinositide 3-kinase/AKT pathway (Suzuki et al., 2005). This evidence concerns the gene RHOA and non-small cell lung carcinoma.